IP Library › Granted Patent US 11,555,196
Granted Patent B2
US 11,555,196 · App. 16/618,704 · Granted Jan 17, 2023

Co-expression of human chaperone proteins in plants for increased expression of heterologous polypeptides

Inventors: Ann Elizabeth Meyers (Plumstead, ZA); Edward Peter Rybicki (Cape Town, ZA); Emmanuel Aubrey Margolin (Rondebosch, ZA)
Assignee: UNIVERSITY OF CAPE TOWN
C12N15/8216C12N15/8258
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,555,196
App. No.
16/618,704
Granted
Jan 17, 2023
Kind
B2
Abstract

The present invention relates to a method for increasing the expression and/or promoting correct folding of a heterologous polypeptide of interest in a plant cell, comprising co-expressing the heterologous polypeptide of interest with a polypeptide encoding a mammalian chaperone protein. The invention also relates to plant cells and plants, which either transiently or stably, co-express the heterologous polypeptide of interest and the chaperone protein.

Claims (24)

1. A method of increasing the expression and/or promoting the correct folding of a heterologous polypeptide of interest in a plant cell, the method comprising:

providing a first nucleic acid encoding a mammalian chaperone protein;

(ii) providing a second nucleic acid encoding a heterologous polypeptide of interest;

(iii) cloning the first and second nucleic acids into at least one expression vector adapted to express a polypeptide in a plant cell;

(iv) transforming or infiltrating a plant cell with the at least one expression vector of step (iii);

(v) co-expressing the heterologous polypeptide of interest and the polypeptide encoding the mammalian chaperone protein in the plant cell; and

(vi) recovering the polypeptide of interest from the plant cell,

wherein the mammalian chaperone protein is selected from calnexin and/or calreticulin.

2. The method of claim 1 , wherein the heterologous polypeptide of interest is a glycoprotein.

3. The method of claim 1 , wherein the expression of the heterologous polypeptide of interest in the plant cell is increased relative to a control plant cell which has only been transformed with the heterologous polypeptide of interest.

4. The method of claim 1 , wherein the co-expression of the heterologous polypeptide of interest and the chaperone protein in the plant cell leads to an at least 1.17-fold increase in the expression of the heterologous polypeptide of interest.

5. The method of claim 1 , wherein the at least one expression vector includes promoters and/or other regulators, operably linked to the first nucleic acid and to the second nucleic acid.

6. A plant cell which is transformed with at least one expression vector, comprising:

a first nucleic acid encoding a mammalian chaperone protein; and

a second nucleic acid encoding a heterologous polypeptide of interest,

wherein the mammalian chaperone protein is selected from calnexin and/or calreticulin.

7. The plant cell of claim 6 , wherein the heterologous polypeptide of interest is a glycoprotein.

8. The plant cell of claim 6 , wherein the expression of the heterologous polypeptide of interest in the plant cell is increased relative to a control plant cell which has only been transformed with the heterologous polypeptide of interest.

9. The plant cell of claim 6 , wherein the co-expression of the heterologous polypeptide of interest and the chaperone protein in the plant cell leads to an at least 1.17-fold increase in the expression of the heterologous polypeptide of interest.

10. The plant cell of claim 6 , wherein the at least one expression vector includes promoters and/or other regulators, operably linked to the first nucleic acid and to the second nucleic acid.

11. The plant cell of claim 6 , wherein the plant cell is from a monocotyledonous or dicotyledonous plant.

12. The plant cell of claim 11 , wherein the plant cell is from a plant selected from the group consisting of maize, rice, sorghum, wheat, cassava, barley, oats, rye, sweet potato, soybean, alfalfa, tobacco, sunflower, cotton, and canola.

13. The plant cell of claim 12 , wherein the plant cell is from a tobacco plant.

14. A plant comprising the plant cell of claim 6 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2020
From: MEYERS, ANN ELIZABETH; RYBICKI, EDWARD PETER; MARGOLIN, EMMANUEL AUBREY
To: UNIVERSITY OF CAPE TOWN
Reel/Frame 052310/0308 →
Priority Claims (1)
GB 1708866 · Jun 2, 2017 · national
Continuity (1)
Related Publication 20210147860A1 · May 20, 2021
Cited By (1)
US 12,398,177